Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma.
Journal: JAMA surgery
Published: December 04, 2024
Early identification of weight loss trajectories in advanced cancer and associations with survival.
Journal: Journal of the National Cancer Institute
Published: August 16, 2024
ERK1/2 Inhibitor Ulixertinib in Pan-cancer Patients with BRAF Fusions or Non-V600E/K Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1L.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 25, 2024
Germline mutations and developmental mosaicism underlying EGFR-mutant lung cancer.
Journal: medRxiv : the preprint server for health sciences
Published: October 09, 2023
TP53 Gain-of-Function and Non-Gain-of-Function Mutations Are Associated With Differential Prognosis in Advanced Pancreatic Ductal Adenocarcinoma.
Journal: JCO precision oncology
Published: May 10, 2023
Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumors.
Journal: Nature cancer
Published: April 05, 2023
Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer.
Journal: Nature communications
Published: November 21, 2022
Future of Teleoncology: Trends and Disparities in Telehealth and Secure Message Utilization in the COVID-19 Era.
Journal: JCO clinical cancer informatics
Published: April 25, 2022
TP53 Gain-of-Function and Non-Gain-of-Function Mutations Are Differentially Associated With Sidedness-Dependent Prognosis in Metastatic Colorectal Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 29, 2021
Attitudes and Perceptions of Multidisciplinary Cancer Care Clinicians Toward Telehealth and Secure Messages.
Journal: JAMA network open
Published: November 24, 2021
Evaluation of endocrine resistance using ESR1 genotyping of circulating tumor cells and plasma DNA.
Journal: Breast cancer research and treatment
Published: December 17, 2020
Last Updated: 09/26/2026